Masaki Anzai

678 total citations
26 papers, 487 citations indexed

About

Masaki Anzai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Masaki Anzai has authored 26 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Surgery. Recurrent topics in Masaki Anzai's work include Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (5 papers). Masaki Anzai is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (5 papers). Masaki Anzai collaborates with scholars based in Japan, Kyrgyzstan and Germany. Masaki Anzai's co-authors include Takashi Ishida, Naofumi Shinagawa, Akifumi Tsuzuku, Fumihiro Asano, Satoshi Morita, Yukihiro Umeda, Miwa Morikawa, Satoshi Oizumi, Joe Shindoh and Tamotsu Ishizuka and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

Masaki Anzai

23 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masaki Anzai Japan	11	397	74	61	41	41	26	487
Mikhail Enikeev Russia	13	398 1.0×	26 0.4×	43 0.7×	50 1.2×	11 0.3×	52	524
Tsukasa Ishiwata Japan	12	314 0.8×	119 1.6×	34 0.6×	77 1.9×	31 0.8×	49	470
Akira Hyogotani Japan	8	169 0.4×	78 1.1×	40 0.7×	30 0.7×	18 0.4×	17	299
William Geddie Canada	7	530 1.3×	52 0.7×	67 1.1×	21 0.5×	17 0.4×	10	610
Agathe Seguin‐Givelet France	13	290 0.7×	190 2.6×	54 0.9×	50 1.2×	25 0.6×	63	512
Sakashi Fujimori Japan	12	508 1.3×	60 0.8×	88 1.4×	110 2.7×	12 0.3×	40	653
Cecil G. Wood United States	7	154 0.4×	87 1.2×	61 1.0×	50 1.2×	13 0.3×	18	316
Naoko Morishita Japan	14	400 1.0×	260 3.5×	37 0.6×	63 1.5×	35 0.9×	62	586
Y Kim South Korea	9	296 0.7×	55 0.7×	135 2.2×	19 0.5×	18 0.4×	16	470
Desiree Weiberg Germany	11	178 0.4×	76 1.0×	184 3.0×	42 1.0×	15 0.4×	21	378

Countries citing papers authored by Masaki Anzai

Since Specialization

Citations

This map shows the geographic impact of Masaki Anzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Anzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Anzai more than expected).

Fields of papers citing papers by Masaki Anzai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Anzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Anzai. The network helps show where Masaki Anzai may publish in the future.

Co-authorship network of co-authors of Masaki Anzai

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Anzai. A scholar is included among the top collaborators of Masaki Anzai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Anzai. Masaki Anzai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakashima, Koki, Yukihiro Umeda, Yoshiki Demura, et al.. (2024). Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies. Oncology. 102(7). 593–603. 3 indexed citations

Nakashima, Koki, Yukihiro Umeda, Yoshiki Demura, et al.. (2023). Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study. BMC Pulmonary Medicine. 23(1). 206–206. 8 indexed citations

Umeda, Yukihiro, Yoshiki Demura, Koki Nakashima, et al.. (2023). Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial. Cancer Medicine. 12(12). 13041–13053. 11 indexed citations

Waseda, Yuko, Masahide Yasui, Toshihiro Takeda, et al.. (2021). Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia. SHILAP Revista de lepidopterología. 13(1). 11–11. 2 indexed citations

Sato, Masayuki, Yukihiro Umeda, Tetsuya Tsujikawa, et al.. (2021). Predictive value of 3′-deoxy-3′-¹⁸F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 9(7). e003079–e003079. 7 indexed citations

Kadowaki, Maiko, Kōichi Sato, Yukihiro Umeda, et al.. (2021). Metal-Stimulated Interleukin-6 Production Through a Proton-Sensing Receptor, Ovarian Cancer G Protein-Coupled Receptor 1, in Human Bronchial Smooth Muscle Cells: A Response Inhibited by Dexamethasone. Journal of Inflammation Research. Volume 14. 7021–7034. 2 indexed citations

Umeda, Yukihiro, Miwa Morikawa, Masaki Anzai, et al.. (2020). Predictive value of integrated ¹⁸F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000349–e000349. 22 indexed citations

Umeda, Yukihiro, Tetsuya Tsujikawa, Masaki Anzai, et al.. (2019). The vertebral 3′-deoxy-3′-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer. European Radiology. 29(7). 3908–3917. 5 indexed citations

Kadowaki, Maiko, Hidenori Yamada, Kōichi Sato, et al.. (2019). Extracellular acidification-induced CXCL8 production through a proton-sensing receptor OGR1 in human airway smooth muscle cells: a response inhibited by dexamethasone. Journal of Inflammation. 16(1). 4–4. 15 indexed citations

10.

Imai, Hisao, Kyoichi Kaira, Kensuke Suzuki, et al.. (2018). A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations. Lung Cancer. 126. 41–47. 31 indexed citations

11.

Yano, Ryoichi, Shinji Yamashita, Kyohei Watanabe, et al.. (2018). Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer. International Journal of Clinical Oncology. 24(3). 256–261. 5 indexed citations

12.

Sasaki, Masato, Masaki Anzai, Miwa Morikawa, et al.. (2017). P2.02-024 Phase I and II Trial of Intrapleural Paclitaxel Injection for Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions. Journal of Thoracic Oncology. 12(1). S861–S862. 1 indexed citations

13.

Anzai, Masaki, Miwa Morikawa, Yukihiro Umeda, et al.. (2017). Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer. Medicine. 96(51). e9320–e9320. 13 indexed citations

14.

Asano, Fumihiro, Takashi Ishida, Naofumi Shinagawa, et al.. (2017). Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial. BMC Pulmonary Medicine. 17(1). 184–184. 33 indexed citations

15.

Ishizaki, Takeshi, Shiro Mizuno, Akio Sakai, et al.. (2015). Blunted Activation of Rho-Kinase in Yak Pulmonary Circulation. BioMed Research International. 2015. 1–5. 14 indexed citations

16.

Umeda, Yukihiro, Yoshiki Demura, Miwa Morikawa, et al.. (2015). Prognostic Value of Dual-Time-Point ¹⁸F-FDG PET for Idiopathic Pulmonary Fibrosis. Journal of Nuclear Medicine. 56(12). 1869–1875. 36 indexed citations

17.

Umeda, Yukihiro, Yoshiki Demura, Masaki Anzai, et al.. (2014). 18F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer. Lung Cancer. 85(1). 47–52. 8 indexed citations

18.

Ishizuka, Tamotsu, Takeshi Hisada, Yosuke Kamide, et al.. (2014). The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications. Journal of Asthma and Allergy. 7. 131–131. 10 indexed citations

19.

Asano, Fumihiro, Naofumi Shinagawa, Takashi Ishida, et al.. (2013). Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy. A Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 188(3). 327–333. 128 indexed citations

20.

Asano, Fumihiro, Yoshihiko Matsuno, Akifumi Tsuzuku, et al.. (2007). Diagnosis of peripheral pulmonary lesions using a bronchoscope insertion guidance system combined with endobronchial ultrasonography with a guide sheath. Lung Cancer. 60(3). 366–373. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact